Lexicon Pharmaceuticals
LXRX
LXRX
121 hedge funds and large institutions have $1.29B invested in Lexicon Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.11% less ownership
Funds ownership: 103.95% → 102.84% (-1.1%)
4% less funds holding
Funds holding: 126 → 121 (-5)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
121
Holding in Top 10
3
Calls
$4.86M
Puts
$2.62M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$5.15M | |
| 3 | +$2.35M | |
| 4 |
PCM
Price Capital Management
Lafayette,
Louisiana
|
+$1.35M |
| 5 |
Citigroup
New York
|
+$1.3M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$8.05M | |
| 3 | -$1.98M | |
| 4 |
PA
Pinnacle Associates
New York
|
-$1.39M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.32M |